Enablement Ruling Extinguishes Broad Antibody Claims, What Comes Next? | Rothwell, Figg, Ernst & Manbeck, P.C.
Last week, a federal court in Delaware unsealed an opinion supporting its grant of summary judgment that U.S. Patent No. 7,033,590 (“the ’590 Patent”) is invalid for lack of enablement....
Source: jdsupra.com